Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

REGULATION OF BRCA1 FUNCTION BY PROTEIN PHOSPHATASE 1

Award Number: R01CA111436
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2005
PERIOD OF PERFORMANCE END DATE: 07/31/2010

Group Awards By:

View Award Description

REGULATION OF BRCA1 FUNCTION BY PROTEIN PHOSPHATASE 1 - DESCRIPTION (provided by applicant): The long-term goal of this research project is to understand the regulation BRCA1 function and to provide new insights into the etiology of breast and ovarian cancer and also provide new targets for the development of novel therapeutic agents. The loss of function of the BRCA1 gene is associated with breast and ovarian cancer. BRCA1 protein has been implicated in fundamental cellular functions, such as DMA repair, recombination, cell cycle regulation and gene transcription. The phosphorylation status of BRCA1 is important for its function. BRCA1 is expressed and phosphorylated in a cell cycle dependent manner and BRCA1 phosphorylation also occurs immediately after DNA damage. Phosphorylation of BRCA1 by kinases such as ATM, ATR, and hCds1, is involved in G2 arrest, which allows cells to undergo DNA damage repair. Once DNA repair is accomplished, cells can be released from G2 arrest and enter mitosis. BRCA1 in mitotic cells is mostly hypophosphorylated. We have demonstrated that protein phosphatase 1 alpha (PP1 alpha) interacts with BRCA1 and dephosphorylates BRCA1 phosphorylated by hCds1. The objective of this proposal is to study the functional significance of this interaction. We hypothesize that PP1 is a critical negative regulator of BRCA1 function. We further hypothesize that dephosphorylation of BRCA1 by PP1 serves as a signal for completion of DNA repair and is involved in G2/M cell cycle progression. We will test this hypothesis by providing functional evidence to support the idea that PP1 regulates fundamental BRCA1 function. We will perform a detailed molecular analysis to determine if PP1 alpha is also responsible for dephosphorylation of BRCA1 phosphorylated by ATM and ATR, and test whether PP1 alpha regulates G2/M progression through dephosphorylation of BRCA1. We have identified a PP1-binding site in BRCA1 and will interrupt the interaction between BRCA1 and PP1 using PP1 non-binding BRCA1 mutants, and dominant-negative truncated BRCA1 proteins containing the PP1-binding motif to investigate whether PP1-binding and dephosphorylation of BRCA1 affect cell survival after DNA damage by modulating cell cycle progression and DNA repair. Lastly, we will also identify regulators of PP1 alpha activity toward BRCA1.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2009 ( Subtotal = $132,101 )
2009	2009	NATIONAL TAIWAN UNIVERSITY	1 ROOSEVELT RD	TAIPEI				TWN	Cancer Cause and Prevention Research	001	4	7/29/2009	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$132,101
2009	2007	MAGEE-WOMENS HEALTH CORPORATION	300 HALKET STREET	PITTSBURGH	PA	15213	ALLEGHENY	USA	Cancer Cause and Prevention Research	000	3	7/27/2009	NON-COMPETING CONTINUATION	$0
														Subtotal = $132,101

Issue Date FY: 2007 ( Subtotal = $185,920 )
2007	2007	MAGEE-WOMENS HEALTH CORPORATION	300 HALKET STREET	PITTSBURGH	PA	15213	ALLEGHENY	USA	Cancer Cause and Prevention Research	000	3	4/27/2007	NON-COMPETING CONTINUATION	$185,920
														Subtotal = $185,920

Issue Date FY: 2006 ( Subtotal = $191,473 )
2006	2006	MAGEE-WOMENS HEALTH CORPORATION	300 HALKET STREET	PITTSBURGH	PA	15213	ALLEGHENY	USA	Cancer Cause and Prevention Research	000	2	5/4/2006	NON-COMPETING CONTINUATION	$191,473
														Subtotal = $191,473

Issue Date FY: 2005 ( Subtotal = $196,080 )
2005	2005	MAGEE-WOMENS HEALTH CORPORATION	300 HALKET STREET	PITTSBURGH	PA	15213	ALLEGHENY	USA	Cancer Cause and Prevention Research	000	1	6/27/2005	NEW	$196,080
														Subtotal = $196,080

Grand Total All Awards = $705,574

Top

All Categories

About

Search

Reports

Data Submission

Award Information

REGULATION OF BRCA1 FUNCTION BY PROTEIN PHOSPHATASE 1

Award Number: R01CA111436

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2005

PERIOD OF PERFORMANCE END DATE: 07/31/2010

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer